PE-22-28.
An investigational mood-modulating peptide for emotional balance.
Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
Patients pursuing investigational mood support under specialist care
• Patients combining cognitive peptides for comprehensive support
This isn't for you if
Investigational. Patients with psychiatric history require specialist clearance and close monitoring.
PE-22-28
PE-22-28 is a peptide studied for fast-acting mood-modulating effects through brain pathways involved in depression and emotional balance.
Mechanism and fit.
PE-22-28 acts on signaling pathways related to mood regulation. It is used in select, physician-guided cognitive/mood protocols.
Who this is typically for.
Patients pursuing investigational mood support under specialist care
• Patients combining cognitive peptides for comprehensive support
What patients
most often ask.
Is PE-22-28 a substitute for antidepressants?
No. PE-22-28 is investigational and not a substitute for established treatments for clinical depression. Patients with significant psychiatric history should work closely with both a psychiatrist and a peptide specialist.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <p>Patients pursuing investigational mood support under specialist care</p><p>
- Patients combining cognitive peptides for comprehensive support</p>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingProvider-directed.
- Typical durationShort cycles, provider-directed.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering PE-22-28, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.